F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Last updated: 2026-08-26 22:20:51 ET
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
There has been a 76% increase in under-construction gas-fired projects amid ‘frenzy’ to build more datacentersThe US has surged ahead of China in ...
While Cavan and Quinn Sullivan star in MLS with the Philadelphia Union, brothers Ronan and Declan have connected with their South Asian heritageRonan ...
Defense files motion to dismiss state case after federal guilty plea but prosecutors say they are prepared to litigateAfter Luigi Mangione admitted in...
Actress Hayden Panettiere was wheeled out of her Los Angeles apartment on a gurney at least twice prior to her tragic death, a neighbor says. Mia Terr...
He pioneered a technique for using computers to predict short-term movements in stock prices, something that proved to be hugely lucrative — when it worked.
Lindsay Clancy called the National Suicide Prevention Lifeline twice before killing her children and was turned away both times, a psychologist testif...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE